These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Measuring the effects of ketamine on mGluR5 using [ Holmes SE; Gallezot JD; Davis MT; DellaGioia N; Matuskey D; Nabulsi N; Krystal JH; Javitch JA; DeLorenzo C; Carson RE; Esterlis I J Cereb Blood Flow Metab; 2020 Nov; 40(11):2254-2264. PubMed ID: 31744389 [TBL] [Abstract][Full Text] [Related]
4. Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: An 18F-FPEB PET Study. Leurquin-Sterk G; Van den Stock J; Crunelle CL; de Laat B; Weerasekera A; Himmelreich U; Bormans G; Van Laere K J Nucl Med; 2016 Nov; 57(11):1746-1752. PubMed ID: 27283933 [TBL] [Abstract][Full Text] [Related]
5. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [ Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382 [TBL] [Abstract][Full Text] [Related]
6. Comparison of two PET radioligands, [ Lohith TG; Tsujikawa T; Siméon FG; Veronese M; Zoghbi SS; Lyoo CH; Kimura Y; Morse CL; Pike VW; Fujita M; Innis RB J Cereb Blood Flow Metab; 2017 Jul; 37(7):2458-2470. PubMed ID: 27629098 [TBL] [Abstract][Full Text] [Related]
7. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry. Wong DF; Waterhouse R; Kuwabara H; Kim J; Brašić JR; Chamroonrat W; Stabins M; Holt DP; Dannals RF; Hamill TG; Mozley PD J Nucl Med; 2013 Mar; 54(3):388-96. PubMed ID: 23404089 [TBL] [Abstract][Full Text] [Related]
8. Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans. Park E; Sullivan JM; Planeta B; Gallezot JD; Lim K; Lin SF; Ropchan J; McCarthy TJ; Ding YS; Morris ED; Williams WA; Huang Y; Carson RE Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1530-41. PubMed ID: 26044120 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study. Salardini E; O'Dell RS; Tchorz E; Nabulsi NB; Huang Y; Carson RE; van Dyck CH; Mecca AP bioRxiv; 2024 Sep; ():. PubMed ID: 39386453 [TBL] [Abstract][Full Text] [Related]
10. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5. de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003 [TBL] [Abstract][Full Text] [Related]
12. Preparation of the metabotropic glutamate receptor 5 (mGluR5) PET tracer [(18)F]FPEB for human use: An automated radiosynthesis and a novel one-pot synthesis of its radiolabeling precursor. Lim K; Labaree D; Li S; Huang Y Appl Radiat Isot; 2014 Dec; 94():349-354. PubMed ID: 25305528 [TBL] [Abstract][Full Text] [Related]
13. Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain. Leurquin-Sterk G; Postnov A; de Laat B; Casteels C; Celen S; Crunelle CL; Bormans G; Koole M; Van Laere K Synapse; 2016 Apr; 70(4):153-62. PubMed ID: 26799447 [TBL] [Abstract][Full Text] [Related]
14. Quantification of metabotropic glutamate subtype 5 receptors in the brain by an equilibrium method using 18F-SP203. Kimura Y; Siméon FG; Zoghbi SS; Zhang Y; Hatazawa J; Pike VW; Innis RB; Fujita M Neuroimage; 2012 Feb; 59(3):2124-30. PubMed ID: 22032949 [TBL] [Abstract][Full Text] [Related]
15. Quantitative positron emission tomography of mGluR5 in rat brain with [(18) F]PSS232 at minimal invasiveness and reduced model complexity. Müller Herde A; Keller C; Milicevic Sephton S; Mu L; Schibli R; Ametamey SM; Krämer SD J Neurochem; 2015 May; 133(3):330-42. PubMed ID: 25439096 [TBL] [Abstract][Full Text] [Related]
16. Study of influence of the glutamatergic concentration of [ Dupont AC; Serrière S; Barantin L; Vercouillie J; Tauber C; Gissot V; Bodard S; Chicheri G; Chalon S; Bonnet-Brilhault PF; Santiago-Ribeiro PM; Arlicot N Transl Psychiatry; 2021 Jan; 11(1):66. PubMed ID: 33473111 [TBL] [Abstract][Full Text] [Related]
17. Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients. Ceccarini J; Leurquin-Sterk G; Crunelle CL; de Laat B; Bormans G; Peuskens H; Van Laere K J Nucl Med; 2020 Feb; 61(2):256-262. PubMed ID: 31481578 [TBL] [Abstract][Full Text] [Related]
18. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [ DeLorenzo C; Gallezot JD; Gardus J; Yang J; Planeta B; Nabulsi N; Ogden RT; Labaree DC; Huang YH; Mann JJ; Gasparini F; Lin X; Javitch JA; Parsey RV; Carson RE; Esterlis I J Cereb Blood Flow Metab; 2017 Aug; 37(8):2716-2727. PubMed ID: 27742888 [TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [ Wang J; He Y; Chen X; Huang L; Li J; You Z; Huang Q; Ren S; He K; Schibli R; Mu L; Guan Y; Guo Q; Zhao J; Xie F Alzheimers Res Ther; 2024 Jan; 16(1):9. PubMed ID: 38217040 [TBL] [Abstract][Full Text] [Related]
20. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [ Kim SE; Joo YH; Son YD; Kim HK; Lee SY; Lee MW; Ido T; Kim JH Brain Struct Funct; 2020 Jul; 225(6):1805-1816. PubMed ID: 32495131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]